In Vitro Nervous System Tools for NAMs

In drug discovery, the nervous system is particularly vulnerable to off-target effects due to its high metabolic demand, complex electrophysiological signaling, and limited regenerative capacity. Early assessment of neurotoxicity and peripheral neuropathy is therefore critical for reducing translational risk. Human neural models can help you evaluate neuronal viability, electrophysiological activity, synaptic function, and network behavior through modalities such as high-content imaging and multi-electrode array (MEA) analysis. These systems support the development and implementation of new approach methodologies (NAM) by enabling mechanistic investigation of neurotoxicity, phenotypic screening in complex neural contexts, and scalable assessment of compound effects in physiologically relevant human platforms. Advanced differentiation kits, defined media systems, and organoid technologies further expand the ability to model region-specific brain development and function.

Human in vitro neural systems can also advance disease modeling and translational research. Platforms modeling neurodegenerative, neurodevelopmental, neuropsychiatric, and neuroimmune disorders support target validation, biomarker discovery, and functional characterization of genetic risk factors. Integration of transcriptomic profiling and electrophysiological readouts enables quantitative assessment of cellular health, synaptic integrity, and network activity. By providing mechanistic and functional data in human-derived systems these models strengthen confidence in candidate selection and improve the ability to predict neurological safety and therapeutic efficacy.

Explore in vitro nervous system tools for your NAM development.